Transforming growth factor-β1 gene polymorphism as a potential risk factor in Turkish patients with laryngeal squamous cell carcinoma

被引:6
作者
Abakay, Candan Demiroz [1 ,3 ]
Pashazadeh, Mehrdad [2 ,3 ]
Ardahanli, Elif [2 ,4 ]
Oral, Haluk Barbaros [2 ]
机构
[1] Bursa Uludag Univ, Dept Radiat Oncol, Fac Med, Bursa, Turkey
[2] Bursa Uludag Univ, Dept Immunol, Fac Med, Gorukle Campus, TR-16059 Bursa, Turkey
[3] Bursa Uludag Univ, Dept Microbiol, Div Immunol, Hlth Sci Inst, Bursa, Turkey
[4] Bursa Uludag Univ, Dept Immunol, Hlth Sci Inst, Bursa, Turkey
关键词
Cytokine; genotyping; larynx cancer; single-nucleotide gene polymorphism; transforming growth factor-beta; GROWTH-FACTOR-BETA; TGF-BETA; CANCER-RISK; ORAL-CANCER; T-CELLS; ASSOCIATION; TGF-BETA-1; SUSCEPTIBILITY; TH17; TOBACCO;
D O I
10.4103/jcrt.JCRT_598_19
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Introduction: Laryngeal cancer is the most common head-and-neck malignancies with more than 20% of all cases. The vast majority of tumors are squamous cell carcinoma (SCC). Several genes encoding different cytokines may play crucial roles in host susceptibility to cancer because cytokine production capacity varies among individuals and depends on cytokine gene polymorphisms. Materials and Methods: The association between cytokine gene polymorphisms with primary laryngeal SCC was investigated. DNA samples were obtained from a Turkish population of eighty patients with primary cancer and fifty healthy controls. Results: All genotyping (interferon-gamma, transforming growth factor-beta 1 [TGF-beta 1], tumor necrosis factor-alpha [TNF-alpha], interleukin [IL]-6, and IL-10) experiments were performed using polymerase chain reaction sequence-specific primers. When compared to the healthy controls, the frequencies of TGF-beta 1 codon 25 (rs1800471) GC genotype and 25 C allele were significantly more common in the patient group. Conclusions: These results suggest that TGF-beta 1 gene polymorphisms may affect host susceptibility to laryngeal cancer.
引用
收藏
页码:144 / 149
页数:6
相关论文
共 40 条
[1]   TGF-β antagonists:: Why suppress a tumor suppressor? [J].
Akhurst, RJ .
JOURNAL OF CLINICAL INVESTIGATION, 2002, 109 (12) :1533-1536
[2]   TNF-α in promotion and progression of cancer [J].
Balkwill, Frances .
CANCER AND METASTASIS REVIEWS, 2006, 25 (03) :409-416
[3]   Relationship of tobacco smoking with GSTM1 gene polymorphism in laringeal cancer [J].
Bardakci, F ;
Canbay, E ;
Degerli, N ;
Coban, L ;
Canbay, E .
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2003, 7 (03) :307-312
[4]   Cytokine gene polymorphisms as potential risk and protective factors in renal cell carcinoma [J].
Bastürk, B ;
Yavasçaoglu, I ;
Vuruskan, H ;
Göral, G ;
Oktay, B ;
Oral, HB .
CYTOKINE, 2005, 30 (01) :41-45
[5]   Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells [J].
Bettelli, E ;
Carrier, YJ ;
Gao, WD ;
Korn, T ;
Strom, TB ;
Oukka, M ;
Weiner, HL ;
Kuchroo, VK .
NATURE, 2006, 441 (7090) :235-238
[6]   Cytokine gene polymorphism in human disease: on-line databases [J].
Bidwell, J ;
Keen, L ;
Gallagher, G ;
Kimberly, R ;
Huizinga, T ;
McDermott, MF ;
Oksenberg, J ;
McNicholl, J ;
Pociot, F ;
Hardt, C ;
D'Alfonso, S .
GENES AND IMMUNITY, 1999, 1 (01) :3-19
[7]   Antitumoral activity of interferon-γ involved in impaired immune function in cancer patients [J].
Brandacher, Gerald ;
Winkler, Christiana ;
Schroecksnadel, Katharina ;
Margreiter, Ralinund ;
Fuchs, Dietmar .
CURRENT DRUG METABOLISM, 2006, 7 (06) :599-612
[8]  
BRUGERE J, 1986, CANCER-AM CANCER SOC, V57, P391, DOI 10.1002/1097-0142(19860115)57:2<391::AID-CNCR2820570235>3.0.CO
[9]  
2-Q
[10]   TGFβ1 Leu10Pro polymorphism contributes to the development of prostate cancer: evidence from a meta-analysis [J].
Cai, Qiliang ;
Tang, Yang ;
Zhang, Minghao ;
Shang, Zhiqun ;
Li, Gang ;
Tian, Jing ;
Jiang, Ning ;
Quan, Changyi ;
Niu, Yuanjie .
TUMOR BIOLOGY, 2014, 35 (01) :667-673